There is a drug being developed in Mycardial Ischaemia and TBI...

There is a drug being developed in Mycardial Ischaemia and TBI in Spain called Aptoll. The results of its preclinical study providing it with a 6 million dollar AUD grant is below for infarct with a 40 percent protection of the heart:


https://www.researchgate.net/figure/Administration-of-4FT-to-rats-following-cardiac-ischemia-reperfusion-I-R-exerts_fig3_366865619

NYR results for NYR-BO3, 86 percent protection. NYR is the only drug in the world right now on this 4 billion indication where it’s far superior than FDA approved drugs and any developing drug:


This current 20 million market cap for NYR is a joke with GLP studies heavily de risking first human trials that start in a month. They don’t need TBI or stroke the company is already outpacing any other drug in a 4 billion dollar market. With peers trading multiples on their valuations compared to NYR, laughable.